Table 1.
Advantages and limitations of different types of cell grafts for the treatment of neuropathic pain models.
Types of cell grafts | Advantages | Limitations |
---|---|---|
Neural stem cells (NSCs) | Extensive self-regeneration capacity | Low transplant efficiency; malignant transformation possible |
Olfactory ensheathing cells (OECs) | Easily available; high cell viability in vitro; promote axonal regeneration and myelination | Limited analgesic effect, even causing hyperalgesia |
Mesenchymal stem cell (MSCs) | Abundant sources; low immunogenicity; Exosomes: a cell-free approach to transplantation | Gender dimorphism; analgesic effects difference: allodynia superior to hyperalgesia |
Bone marrow mononuclear cells (BMMCs) | No need for in vitro expansion; facilitate blood vessel formation and tissue repair | May cause neuroapoptosis |
GABAergic cells | High survival rate and long survival time | Validate only in rat animal models |
Genetically modified cells | Enhance cell viability; improve analgesic effect | Biosafety issues to be considered; risk of tumor formation |